 |
|
|
| |
|
Borderline Personality Disorder
From
Research to Treatment: Advancing the Agenda
|
|
Saturday, October 6, 2007
▪
Fort
Worth Botanic Garden
|
|
Moderator for the Day:
Peter Kowalski, MD
Diplomate, American Board of Psychiatry and
Neurology
General, Child and Adolescent Psychiatry
Fort Worth, Texas
|
|
Welcome |
|
|
Perry D. Hoffman, PhD
President, National Education Alliance for
Borderline Personality Disorder
Rye, New York
|
|
|
|
Borderline Personality
Disorder: Charting the Future |
1 hr 12
min 4 sec
|
 |
|
|
|
John Oldham, MD, MS
Senior Vice President & Chief of Staff, The
Menninger Clinic
Executive Vice Chair for Clinical Affairs and
Development
Professor, Menninger Department of Psychiatry
and Behavioral Sciences,
Baylor College of Medicine,
Houston, Texas
|
Focus |
| |
A dimensional approach to defining BPD
|
| |
Latest information about evidence-based treatment of
BPD |
| |
The longitudinal course of this disorder |
|
Abstract
Borderline Personality Disorder (BPD) has emerged
into widespread recognition as a highly disabling
condition that is prevalent in clinical
populations. An evidence-based practice guideline
has been developed for treatment of patients with
BPD, and research is clarifying the neurobiology and
phenomenology of the disorder. Heritable endophenotypes such as affective instability and
impulsive aggression may underlie an array of
symptom patterns, a dimensional trait-based approach
that could lead to enhanced understanding of this
disorder. Psychotherapy itself, the evidence-based
primary recommended treatment, is now known to be
correlated with biological changes in the brain at
the neuromolecular level, shedding light on the
mechanism of action of this therapeutic form of
learning and memory. Longitudinal studies have
clarified that our current defining criteria of BPD
may need to be unpacked and segregated into at least
two categories: relatively stable traits, and
episodic self-injurious behaviors or symptoms that
are sensitive to environmental circumstances. |
|
|
|
|
An Overview of Treatment
Strategies for Borderline Personality Disorder |
1 hr 4
min 33 sec
|
 |
|
|
|
Glen Gabbard, MD
Brown Foundation Professor of Psychoanalysis
Director, Baylor Psychiatry Clinic,
Houston, Texas
|
Objectives: |
| |
Participants will gain knowledge about the
evidence-based psychotherapies that have been shown
to be efficacious in the treatment of borderline
personality disorder. |
| |
Participants will be able to develop an algorithm of
pharmacotherapy agents for the treatment of
borderline personality disorder. |
|
Abstract
The American Psychiatric Association Practice
Guidelines issued in 2001 suggested that a
combination of psychotherapy and medication would be
the optimal treatment approach to borderline
personality disorder. In the last six years since
the appearance of the Guidelines, much greater
information is available to guide clinicians in the
implementation of a treatment plan. Data
demonstrating efficacy from randomized controlled
trials suggest that several psychotherapeutic
strategies are useful: 1) Dialectical Behavior
Therapy, 2) Mentalization-Based Therapy, 3)
Transference-Focused Psychotherapy, 4)
Schema-Focused Therapy, and 5) Supportive
Psychotherapy. These psychotherapies will be
outlined and discussed in terms of clinical
usefulness, and the data stemming from the studies
will be critiqued. A number of medications have
been shown to be efficacious in placebo-controlled
randomized trials. These medications can be applied
according to symptom clusters and algorithms, and
will be illustrated and discussed.
|
|
|
|
|
Recent
Developments:
Mentalization Based Therapy (MBT)
for Borderline Personality
Disorder |
1 hr 28 min 2 sec;
Go to Video
|
 |
|
|
|
Anthony W. Bateman, MA, MD, FRCPsych
Consultant Psychiatrist in Psychotherapy
Visiting Professor, University College,
London, England
Visiting Professor Consultant,
Menninger Clinic,
Baylor College of Medicine,
Houston, Texas
Abstract
Mentalization is the process by which we implicitly
and explicitly interpret the actions of ourselves
and others as meaningful on the basis of intentional
mental states (e.g., desires, needs, feelings,
beliefs, & reasons).
We mentalize interactively and emotionally when with
others. Each person has the other persons mind in
mind (as well as their own) leading to
self-awareness and other awareness. We have to be
able to continue to do this in the midst of
emotional states but borderline personality disorder
is characterised by a loss of capacity to mentalize
when emotionally charged attachment relationships
are stimulated. The aim of MBT is to increase this
capacity in order to ensure better regulation of
affective states and to increase interpersonal and
social function. Therapy has been shown to be more
effective than treatment as usual in the context of
a partial hospital programme both at the end of
treatment and at 8 year follow-up. Some results from
this long term follow-up will be presented. With the
support of a grant from the Borderline Personality
Disorder Research Foundation (BPDRF), a randomised
controlled trial of MBT in an out-patient setting
has also been completed. Some preliminary results
will be presented. Finally some clinical examples of
mentalizing interventions will be given as well as a
rationale of why some commonly used therapeutic
interventions might be harmful in BPD. |
|
Objectives of presentation
Following the presentation participants should be
able: |
| |
To understand mentalization |
| |
To appraise the evidence for its effectiveness in
treatment of BPD |
| |
To recognise mentalizing and non-mentalizing
interventions |
|
|
|
|
Interactive Panel: Isn’t It time for a New Name? |
|
|
|
|
|
|
Family, Consumer, Clinician Forum |
|
|
|
|
|
|
|
|
|
© 2005-2008
National Education Alliance for Borderline Personality Disorder
PO
Box
974, Rye, New York 10580
914-835-9011
|
|
|
|
Site by AMS Web Services
|
|